It would be easy to be cynical about the claims made on You Tube or in blogs regarding pharamaceuticals and the inherent problems of drug development in a free market, but an article in The Independent featured in The Week cites the chair of the UK Government's antibiotic resistance working group, Peter Hawkey. Presumably mainstream enough?
An estimated 25,000 people a year die in the EU of antibiotic-resistant infections. Why are drugs companies not developing new drugs for this? No money it. Not as profitable as heart disease or cancer.
A direct example of profit before people. An RBE would be the potent drug against such evil.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment